Literature DB >> 32843736

Secukinumab effective for nr-axSpA.

Sarah Onuora1.   

Abstract

Year:  2020        PMID： 32843736     DOI： 10.1038/s41584-020-0496-z

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.

Authors:  Atul Deodhar; Ricardo Blanco; Eva Dokoupilová; Stephen Hall; Hideto Kameda; Alan J Kivitz; Denis Poddubnyy; Marleen van de Sande; Anna S Wiksten; Brian O Porter; Hanno B Richards; Sibylle Haemmerle; Jürgen Braun
Journal:  Arthritis Rheumatol       Date:  2020-11-24       Impact factor: 15.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.